Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of property and equipment, net

Property and equipment, net consisted of the following:

	As of June 30, 2025		As of December 31, 2024
Building and land	$	14,078	$	14,078
Leasehold improvements	824		824
Computer hardware and software	896		875
Office and lab equipment	13,061		11,620
Furniture and fixtures	2,024		1,811
	$	30,883	$	29,208
Accumulated depreciation	(14,281)		(12,206)
	16,602		17,002
Equipment not yet in service	1,991		318
Property and equipment, net	$	18,593	$	17,320

Schedule of other noncurrent assets

Other non-current assets consisted of the following:

	As of June 30, 2025		As of December 31, 2024
Operating lease right-of-use assets	$	34,242	$	36,391
Other	2,963		3,134
Other non-current assets	$	37,205	$	39,525

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following:

	As of June 30, 2025		As of December 31, 2024
Accrued development milestones	$	15,153	$	—
Accrued employee compensation and benefits	12,109		154
Accrued clinical trial costs	33,920		38,432
Operating lease liabilities - current portion	4,696		3,802
Other accrued expenses and other current liabilities	12,848		9,099
Accrued expenses and other current liabilities	$	78,726	$	51,487